The Daily Mail reports today that trials of a magic bullet medicine – a polypill – are underway in London. It’s a pill that combines medication for raised blood pressure, high cholesterol and to reduce blood clotting. The sceptics said it would never happen because drugs companies wouldn’t make any money. Whether they do or not, it’s happening. Another objection will be that it will turn us all into patients – something I have written about before – but I don’t believe is the case with this. This will be a godsend for people with heart disease or at risk of stroke who struggle to remember which pill to take and when – or simply resent being given so many pills that they rattle. This could transform the chances of people in developing countries of getting the medication that they need. The only caveat is that we prescribe this polypill for those who need it – that the pool of those defined as ‘at risk’ is not an ever widening one – but that goes for all medicines.
- Finalists and judges joined AXA PPP Healthcare and 2020Health at the Design Museum last night to celebrate... fb.me/9EMNpH9Qm 5 hours ago
- Fabulous Night at the Museum! 2020health.wordpress.com/2017/04/28/fab… https://t.co/ErjSgXd2s4 5 hours ago
- RT @HealthTechYou: ⚡️ “Catch up with our #HealthTechAwards” twitter.com/i/moments/8579… 7 hours ago